Navigation Links
GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2007 Financial Results
Date:3/14/2008

ATLANTA, March 14 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), an Atlanta-based biotechnology company focused on development of an HIV/AIDS vaccine, today announced its financial results for the fourth quarter and year ended December 31, 2007.

GeoVax recorded a net loss of $1,155,870 for the fourth quarter ended December 31, 2007, as compared to $157,276 for the comparable period in 2006. For the full year of 2007, the Company recorded a net loss of $4,241,796 as compared to $584,166 in 2006. GeoVax's operating results fluctuate due to the timing of activities and related costs associated with its vaccine research and development activities. The overall increase in the Company's net loss from 2006 to 2007 is primarily attributable to:

-- Substantial costs for manufacture and testing of AIDS vaccines for

Phase 2 human trials planned for summer 2008.

-- Increased research and development expenditures as the Company

continued to support its three ongoing Phase 1 human AIDS vaccine

clinical trials and prepares for initiation of Phase 2 trials in 2008.

-- Lower grant revenues during 2007. During the first nine months of

2007, GeoVax had no grant revenues. During the fourth quarter of 2007,

the Company recorded $234,004 in grant revenues associated with an

estimated $15 million, 5 year grant from the NIH (see discussion

below).

-- Overall higher general and administrative costs due to the additional

costs associated with being a public company subsequent to the merger

between Dauphin Technology, Inc. and GeoVax, Inc. in September 2006.

These higher costs included expansion of the Company's management team,

initiation of an investor relations program, increased legal and

accounting costs, and costs associated with achieving compliance with

the Sarbanes-Oxley Act of 2002.

-- Stoc
'/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. GeoVax Vaccine Only 5th AIDS Vaccine Moving to Phase 2 Human Trials
2. Dr. Harriet Robinson Joins GeoVax Team as V.P. of R & D to Accelerate AIDS Vaccine Trials Program
3. GeoVax Labs, Inc. Selected by Georgia Bio as 2008 Deal of the Year Award Winner in Life Sciences Industry
4. GeoVax Labs, Inc. Selects Financial Relations Board as Investor Relations Counsel
5. GeoVax Labs, Inc. Third Quarter Financial Results and Operational Update
6. Excellent Results Received from GeoVaxs Full-Dose HIV/AIDS Vaccine Trial
7. GeoVax Labs, Inc. Comments on Discontinuance of Mercks HIV Vaccine Trial
8. GeoVax Successful HIV/AIDS Vaccine Trial Data Presented at AIDS Vaccine 2007 Conference
9. Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer
10. Memory Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Financial Results
11. PLC Systems Reports Fourth Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... , April 1, 2015  Galmed Pharmaceuticals Ltd. ... company focused on the development and commercialization of ... liver diseases and cholesterol gallstones, today announced that ... Vice President of Clinical Operations. Mr. ... clinical operations, development and regulatory affairs.  From 2005 ...
(Date:4/1/2015)... Minn. , April 1, 2015  EnteroMedics ... devices using neuroblocking technology to treat obesity, metabolic ... the Company has entered into a partnership with ... access to vBloc® Therapy, delivered via the Maestro® ... System is approved for adults with a BMI ...
(Date:3/31/2015)... and ORANGEBURG, N.Y., March 31, 2015 Uroplasty, ... announced the completion of their merger. The merger ... of the all-stock combination creates a new medical ... April 1, 2015, Cogentix Medical, Inc. will trade ... Medical will have its U.S. headquarters in ...
Breaking Medicine Technology:Galmed Pharmaceuticals Announces the Appointment of George Tonelli as Vice President of Clinical Operations 2Galmed Pharmaceuticals Announces the Appointment of George Tonelli as Vice President of Clinical Operations 3EnteroMedics Announces Partnership with American HealthCare Lending to Support Patient Access and Enhance Affordability of vBloc Therapy 2EnteroMedics Announces Partnership with American HealthCare Lending to Support Patient Access and Enhance Affordability of vBloc Therapy 3EnteroMedics Announces Partnership with American HealthCare Lending to Support Patient Access and Enhance Affordability of vBloc Therapy 4Uroplasty and Vision-Sciences Complete Merger 2Uroplasty and Vision-Sciences Complete Merger 3Uroplasty and Vision-Sciences Complete Merger 4
... show evidence of additional protection,against infection with ... 17, 2007 /PRNewswire-FirstCall/ -- The,GlaxoSmithKline cervical cancer ... preventing precancerous,lesions due to cancer-causing human papillomavirus ... years in an extended follow-up trial, according ...
... Alnylam,Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi ... for Cancer,Research (AACR) 2007 Annual Meeting that ... ALN-VSP01, for the,treatment of liver cancer and ... program. ALN-VSP01 is an RNAi therapeutic that ...
Cached Medicine Technology:Cervarix, GSK Cervical Cancer Candidate Vaccine, Demonstrates 100,Percent Protection Against Precancerous Lesions Caused By,Cancer-Causing Human Papillomavirus Types 16 & 18 for More Than,Five Years 2Cervarix, GSK Cervical Cancer Candidate Vaccine, Demonstrates 100,Percent Protection Against Precancerous Lesions Caused By,Cancer-Causing Human Papillomavirus Types 16 & 18 for More Than,Five Years 3Cervarix, GSK Cervical Cancer Candidate Vaccine, Demonstrates 100,Percent Protection Against Precancerous Lesions Caused By,Cancer-Causing Human Papillomavirus Types 16 & 18 for More Than,Five Years 4Cervarix, GSK Cervical Cancer Candidate Vaccine, Demonstrates 100,Percent Protection Against Precancerous Lesions Caused By,Cancer-Causing Human Papillomavirus Types 16 & 18 for More Than,Five Years 5Alnylam Announces Advancement of a New RNAi Therapeutic Development,Program for the Treatment of Liver Cancer 2Alnylam Announces Advancement of a New RNAi Therapeutic Development,Program for the Treatment of Liver Cancer 3Alnylam Announces Advancement of a New RNAi Therapeutic Development,Program for the Treatment of Liver Cancer 4Alnylam Announces Advancement of a New RNAi Therapeutic Development,Program for the Treatment of Liver Cancer 5
(Date:4/1/2015)... 01, 2015 Franklin University, one of ... announce the establishment of the Greta J. Russell Medical ... possible through the generous gift of $100,000 from Medical ... behalf of Medical Mutual to University representatives, Dr. ... of Advancement & Strategic Relations. , “We are ...
(Date:4/1/2015)... (PRWEB) April 01, 2015 Pricing Healthcare ... last several months, bring coverage to a third of all ... states of Massachusetts, Kansas, and Iowa, and the first dedicated eye ... center in Dallas, TX was also added. , In addition, the ... to and general interest in the platform continue to grow across ...
(Date:4/1/2015)... Patients with inoperable mesothelioma may soon ... to the FDA’s approval of CRS-207’s orphan drug application ... on the Surviving Mesothelioma website. , CRS-207 ... of the bacteria that causes the food-borne illness Listeriosis. ... funding and other incentives to support continued testing and ...
(Date:4/1/2015)... 2015 Phybridge Inc., a provider ... today its strategic partnership with SaskTel in a ... the businesses of Saskatchewan. SaskTels’ Integrated Business Communications ... that offers users a hosted IP unified communications ... The objective of IBC is to offer an ...
(Date:4/1/2015)... 01, 2015 The dearth of ... are set to retire in the next five ... demand for laboratory automation. The application of advanced ... it ensures timely progress and efficiency with minimal ... lab automation in high-throughput screening, combinatorial chemistry, automated ...
Breaking Medicine News(10 mins):Health News:Franklin University Receives Gift to Create the Greta J. Russell Medical Mutual of Ohio Scholarship 2Health News:Franklin University Receives Gift to Create the Greta J. Russell Medical Mutual of Ohio Scholarship 3Health News:PricingHealthcare.com Adds Facilities in 5 States, Hits 10,000 Monthly Users Milestone 2Health News:PricingHealthcare.com Adds Facilities in 5 States, Hits 10,000 Monthly Users Milestone 3Health News:Orphan Drug Approval May Mean New Treatment Option for Mesothelioma, According to Surviving Mesothelioma 2Health News:Phybridge and SaskTel Team Up to Eliminate Network Barriers for IP Telephony and Unified Communications Migration 2Health News:Phybridge and SaskTel Team Up to Eliminate Network Barriers for IP Telephony and Unified Communications Migration 3Health News:Laboratory Accessories Market Worth $504.7 Million by 2020 – New Research Report by MarketsandMarkets 2Health News:Laboratory Accessories Market Worth $504.7 Million by 2020 – New Research Report by MarketsandMarkets 3
... LUGANO, Switzerland, September 9 As part ... been appointed as new,CEO in the American subsidiary, Helsinn ... Officer of the recently acquired,Helsinn Therapeutics, and has held ... Development and in Research. , ...
... ... Patient Education Reference Center™ Available online at www.ebscohost.com/flu . The Latest Evidence-based ... ... -- Concerns about Pandemic H1N1 and the upcoming flu season have people on alert ...
... ... Year , ... GA (PRWEB) September 9, 2009 -- Kennesaw, Georgia-based Cobb Pediatric Therapy Services, a pediatric ... systems across the U.S., has been named one of the country,s fastest growing private ...
... ... Inc. today announced the completion of over a dozen more HL7 ... in the medical industry. pMDsoft,s industry-leading interface engine has allowed ... data entry and increasing the accuracy of their claims. The ...
... , - Choosing a More Appropriate ... to Improvement , The first results of ... presented today at the 6th congress,of the European Federation of Chapters ... (Logo: http://www.newscom.com/cgi-bin/prnh/20090909/358726 ) , ...
... owners and employees are among those who stand to ... current health reform proposals under consideration by Congress according ... to extend health care coverage to everyone and repair ... costs, high broker fees, underwriting, and a lack of ...
Cached Medicine News:Health News:New Chief Executive Officer and Vice President Commercial Operations USA at the Helsinn Group's American subsidiary, Helsinn Therapeutics (U.S.) Inc. 2Health News:EBSCO Publishing Makes Evidence-Based Flu Resources Freely Available 2Health News:EBSCO Publishing Makes Evidence-Based Flu Resources Freely Available 3Health News:Cobb Pediatric Therapy Services Is Recognized by Inc. Magazine as One of the Fastest Growing Private Companies 2Health News:pMDsoft Announces Interfaces with Additional EMR, EHR, Practice Management, Hospital and Billing Systems 2Health News:pMDsoft Announces Interfaces with Additional EMR, EHR, Practice Management, Hospital and Billing Systems 3Health News:pMDsoft Announces Interfaces with Additional EMR, EHR, Practice Management, Hospital and Billing Systems 4Health News:pMDsoft Announces Interfaces with Additional EMR, EHR, Practice Management, Hospital and Billing Systems 5Health News:First Results From Major European Patient Survey Show Devastating Impact of Living With Breakthrough Cancer Pain 2Health News:First Results From Major European Patient Survey Show Devastating Impact of Living With Breakthrough Cancer Pain 3Health News:Small businesses would see lower costs, more comprehensive coverage from health reform 2Health News:Small businesses would see lower costs, more comprehensive coverage from health reform 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: